The new major shareholder of Elanix Biotechnologies AG, Mrs. Fang Bao, has announced that she requests to convene an extraordinary shareholder meeting to replace the chairman of the supervisory board, Mr. Jürgen Kullmann. His deputy, Mrs. Abigael de Buys Roessingh, announced to resign from the Supervisory Board with effect from 8 March 2019. A successor should be appointed by juridical order in a timely manner. Mrs. Fang Bao will remain in office as Supervisory Board member. A date and the agenda for the General Meeting have not yet been announced. The Management Board will keep the shareholders informed.